Results 261 to 270 of about 129,974 (285)
Some of the next articles are maybe not open access.

Endometrial Cancer

Obstetrical & Gynecological Survey, 2020
(Abstracted from N Engl J Med 2020;383:2053–2064) Incidence rates and associated mortality of endometrial cancer continue to rise in the United States, including a sustained rise in cases among women younger than 50 years. This trend is partially driven by the rising rates of obesity, one of the most important risk factors for this disease.
Karen H, Lu, Russell R, Broaddus
openaire   +4 more sources

Endometrial Cancer

Obstetrics & Gynecology, 2008
This review summarizes the epidemiology, prevention, diagnosis and treatment, and prognosis of endometrial carcinoma. Although the incidence of disease has remained stable, the death rate has increased over 100% over the last two decades. Precursor lesions of complex hyperplasia with atypia are associated with an endometrial carcinoma in over 40% of ...
Alexey Davydov, V. Craig Jordan
openaire   +4 more sources

Endometrial cancer

The Lancet, 2016
Endometrial cancer is the most common gynaecological tumour in developed countries, and its incidence is increasing. The most frequently occurring histological subtype is endometrioid adenocarcinoma. Patients are often diagnosed when the disease is still confined to the uterus.
Morice, P.   +4 more
openaire   +4 more sources

Endometrial Cancer

Oncology Research and Treatment, 2003
Radical surgery including complete pelvic and para-arortic lymph node dissection (LND) is both the main therapeutic effort and the decisive staging procedure in patients with invasive endometrial cancer (EC) and should be performed in specialized institutions.
V, Hanf, A R, Günthert, G, Emons
openaire   +2 more sources

Endometrial Cancer

International Journal of Gynecological Cancer, 1999
Endometrial cancer is the most common gynecologic malignancy in the United States, with 37,400 new cases and 6400 deaths estimated to occur in 1999. The epidemiology of endometrial cancer has been widely characterized; nevertheless, efforts continue to more precisely define risk factors for the disease.
openaire   +4 more sources

Endometrial cancer

Current Problems in Cancer, 1997
Carcinoma of the uterine corpus (endometrial cancer) remains the gynecologic malignant disease with the highest annual prevalence in the United States. The most common histologic type is adenocarcinoma, although more aggressive variants (e.g., papillary serous carcinoma and clear cell carcinoma) have been identified.
K M, Greven, B W, Corn
openaire   +2 more sources

Estrogens and Endometrial Cancer

Journal of Urology, 1980
The role of ovarian hormones in endometrial carcinoma was first suspected on the basis of observations of certain endocrine disorders, e.g. polycystic ovary syndrome and hormone secreting ovarian tumors1,2. Recently postmenopausal estrogen therapy became the center of controversy on possible endometrial carcinogenicity3–50.
P Spavento   +8 more
openaire   +4 more sources

The epidemiology of endometrial cancer

Gynecologic Oncology, 1991
The descriptive and analytical epidemiology of endometrial cancer is reviewed. Over the last few decades, age-standardized incidence rates have been rising in several countries. The rise has been even greater in terms of absolute numbers of cases, and hence public health implications, due to the aging of the population.
Silvia Franceschi   +4 more
openaire   +4 more sources

Endometrial cancer

Seminars in Oncology Nursing, 2002
To provide an update for nurses involved in the care of women at risk or being treated for endometrial cancer.Review articles, research reports, and medical and nursing text-books.Endometrial cancer is the most common gynecologic malignancy. Although most women with endometrial cancer present with early stage disease and have an excellent chance of ...
openaire   +2 more sources

Genetics of endometrial cancer

Familial Cancer, 2014
Women who report a history of endometrial cancer in a first-degree relative are at increased risk of endometrial cancer, with a hazard ratio of 1.5 to 2.0. Only a minority of patients with familial endometrial cancer have a recognized cancer syndrome.
Yakir Segev   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy